Literature DB >> 12110498

Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma.

M B Godfried1, M Veenstra, A Valent, P v Sluis, P A Voûte, R Versteeg, H N Caron.   

Abstract

Loss of heterozygosity (LOH) of the distal part of the short arm of chromosome 1 in neuroblastoma is a well characterised phenomenon. In addition, previous reports have described interstitial deletions outside the common region of loss on chromosome 1p36, suggesting additional tumour suppressor loci. In this study, we have searched extensively for interstitial 1p deletions in a panel of 67 neuroblastoma samples from clinically-detected cases. We used three VNTR probes and 10 dinucleotide markers from the 1p32-36 regions reported to show interstitial deletions. Fifteen (22%) tumours showed telomeric LOH without evidence for more proximal interstitial deletions. Forty-five tumours showed no LOH or allelic imbalance. Seven (10%) tumours demonstrated allelic imbalance for one or more markers. These tumours were subsequently analysed by fluorescent in situ hybridisation (FISH) and flow cytometry. The patterns found in all seven tumours were consistent with copy number changes of the entire chromosome 1, without evidence for interstitial deletions. This study indicates that interstitial deletions of chromosome 1p are rare in clinically-detected neuroblastoma when analysed by a combination of molecular and cytogenetic techniques.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110498     DOI: 10.1016/s0959-8049(02)00137-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

Review 1.  Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.

Authors:  Alea A Mills
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

2.  The tumor suppressor Chd5 is induced during neuronal differentiation in the developing mouse brain.

Authors:  Assaf Vestin; Alea A Mills
Journal:  Gene Expr Patterns       Date:  2013-10-09       Impact factor: 1.224

3.  Chd5 requires PHD-mediated histone 3 binding for tumor suppression.

Authors:  Shilpi Paul; Alex Kuo; Thomas Schalch; Hannes Vogel; Leemor Joshua-Tor; W Richard McCombie; Or Gozani; Molly Hammell; Alea A Mills
Journal:  Cell Rep       Date:  2013-01-10       Impact factor: 9.423

Review 4.  The quest for the 1p36 tumor suppressor.

Authors:  Anindya Bagchi; Alea A Mills
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

5.  Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma.

Authors:  Lei Xu; Fengling Shao; Tengling Luo; Qijun Li; Dongmei Tan; Yi Tan
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

6.  Large 1p36 Deletions Affecting Arid1a Locus Facilitate Mycn-Driven Oncogenesis in Neuroblastoma.

Authors:  Jesus García-López; Kirby Wallace; Joel H Otero; Rachelle Olsen; Yong-Dong Wang; David Finkelstein; Brian L Gudenas; Jerold E Rehg; Paul Northcott; Andrew M Davidoff; Kevin W Freeman
Journal:  Cell Rep       Date:  2020-01-14       Impact factor: 9.995

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.